Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
1
2
2
1
0
0
Croissance des revenus (H/H)
-67%
0%
100%
--
--
--
Coût des ventes
0
0
0
0
0
0
Bénéfice brut
0
2
1
1
0
0
Vente, Général et Administration
5
4
5
5
4
3
Recherche et développement
4
5
8
6
5
4
Frais d'exploitation
10
11
15
12
10
8
Autres revenus (charges) non opérationnels
0
0
0
0
0
0
Bénéfice avant impôts
-9
-11
-8
-12
-9
-7
Charge d'impôt sur le revenu
--
--
--
0
0
0
Bénéfice net
-16
-11
-8
-16
-9
-16
Croissance du bénéfice net
45%
38%
-50%
78%
-44%
129%
Actions en circulation (diluées)
2.96
0.74
0.01
0
0
0
Variation des actions (H-H)
231%
3,802%
850%
100%
0%
--
EPS (dilué)
-5.58
-14.87
-436.05
-8,244.5
-9,308.99
-16,594
Croissance du EPS
-56.99%
-97%
-95%
-11%
-44%
-83%
Flux de trésorerie libre
-7
-9
-14
-11
-13
-9
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
0%
100%
50%
100%
0%
0%
Marge opérationnelle
-1,000%
-450%
-650%
-1,100%
0%
0%
Marge bénéficiaire
-1,600%
-550%
-400%
-1,600%
0%
0%
Marge du flux de trésorerie libre
-700%
-450%
-700%
-1,100%
0%
0%
EBITDA
-10
-9
-13
-11
-10
-8
Marge EBITDA
-1,000%
-450%
-650%
-1,100%
0%
0%
D&A pour le résultat opérationnel
0
0
0
0
0
0
EBIT
-10
-9
-13
-11
-10
-8
Marge EBIT
-1,000%
-450%
-650%
-1,100%
0%
0%
Taux d'imposition effectif
--
--
--
0%
0%
0%
Follow-Up Questions
Quels sont les états financiers clés de SINTX Technologies Inc ?
Quels sont les ratios financiers clés pour SINT ?
Comment les revenus de SINTX Technologies Inc sont-ils répartis par segment ou géographie ?
SINTX Technologies Inc est-elle rentable ?
SINTX Technologies Inc a-t-elle des passifs ?
Combien d'actions en circulation SINTX Technologies Inc a-t-elle ?
Statistiques clés
Clôture préc.
$2.72
Prix d'ouverture
$2.72
Plage de la journée
$2.72 - $3.04
Plage de 52 semaines
$1.71 - $7.36
Volume
21.0K
Volume moyen
56.5K
BPA (TTM)
-4.66
Rendement en dividend
--
Capitalisation boursière
$11.4M
Qu’est-ce que SINT ?
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.